Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-27 @ 4:02 AM
Study NCT ID:
NCT00806494
Status:
COMPLETED
Last Update Posted:
2011-01-26
First Post:
2008-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
UK Study Assessing Flexible Dose Fesoterodine in Adults
Sponsor:
Pfizer
Organization:
Study Overview
Official Title:
A 12 Week, Multi-centre, Open Label Study To Evaluate The Efficacy, Tolerability And Safety Of A Fesoterodine Flexible Dose Regimen In Patients With Overactive Bladder.
Status:
COMPLETED
Status Verified Date:
2011-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SAFINA
Brief Summary:
To explore the effects of fesoterodine when used in a flexible dose manner
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: